Page 14 - Research Models News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Bell Bank cut its holdings in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 7.8% in the fourth quarter, Holdings Channel reports. The institutional investor owned 1,716 shares of the medical research company’s stock after selling 146 shares during the quarter. Bell Bank’s holdings in Charles River Laboratories International were worth $406,000 at […]

Bell Bank decreased its position in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 7.8% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 1,716 shares of the medical research company’s stock after selling 146 shares during the period. Bell Bank’s holdings in Charles River […]

Shares of Charles River Laboratories International, Inc. (NYSE:CRL – Get Free Report) have received an average rating of “Moderate Buy” from the twelve research firms that are covering the stock, MarketBeat reports. Five analysts have rated the stock with a hold recommendation and seven have issued a buy recommendation on the company. The average 12 […]

Reinhart Partners LLC. lessened its stake in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 18.2% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 72,895 shares of the medical research company’s stock after selling 16,174 shares […]

Reinhart Partners LLC. cut its stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 18.2% in the 4th quarter, Holdings Channel reports. The fund owned 72,895 shares of the medical research company’s stock after selling 16,174 shares during the quarter. Reinhart Partners LLC.’s holdings in Charles River Laboratories International were […]